N. Strick

S. Jiang, A. Neurath, N. Strick, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Some properties of hepatitis B core antigen isolated from serum of infected humans.

A. Neurath, N. Strick, S. Huang, 1978, The Journal of general virology.

H‐2 linked genetic control of immune responsiveness to hepatitis B surface antigen (HBsAg) in mice

A. Neurath, N. Strick, D. Stark, 1983, Journal of medical virology.

Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populations.

A. Neurath, N. Strick, W. Szmuness, 1981, American journal of epidemiology.

3-Hydroxyphthaloyl β-Lactoglobulin. III. Antiviral Activity against Herpesviruses

A. Neurath, N. Strick, Yunyao Li, 1998 .

A herpesvirus inhibitor from bovine whey

A. Neurath, N. Strick, Yunyao Li, 1996, The Lancet.

Rapid Prescreening for Antiviral Agents against HIV-1 Based on Their Inhibitory Activity in Site-Directed Immunoassays. II. Porphyrins Reacting with the V3 Loop of gp120

Shibo Jiang, A. Neurath, N. Strick, 1992 .

Quantitation of cellulose acetate phthalate in biological fluids as a complex with ruthenium red.

A. Neurath, N. Strick, A. Neurath, 2001, Analytical biochemistry.

Tin Protoporphyrin IX Used in Control of Heme Metabolism in Humans Effectively Inhibits HIV-1 Infection

A. Debnath, Shibo Jiang, A. Neurath, 1994 .

Enzyme-linked fluorescence immunoassays using beta-galactosidase and antibodies covalently bound to polystyrene plates.

A. Neurath, N. Strick, 1981, Journal of virological methods.

Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.

Shibo Jiang, S. Jiang, A. Neurath, 1999, Biologicals : journal of the International Association of Biological Standardization.

Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus

A. R. Neurath, S. Kent, A. Neurath, 1986, Cell.

Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands.

A. Neurath, N. Strick, M. Petit, 1991, Molecular immunology.

Hepatitis B virus contains pre-S gene-encoded domains

S. Kent, A. Neurath, N. Strick, 1985, Nature.

Radioimmunoassay for albumin-binding sites associated with HBsAg: correlation of results with the presence of e-antigen in serum.

A. Neurath, N. Strick, 1979, Intervirology.

An antigen detected frequently in human sera with elevated levels of alanine aminotransferase: a potential marker for non-A, non-B hepatitis.

A. Neurath, N. Strick, W. Szmuness, 1980, The Journal of general virology.

Affinity chromatography of hepatitis B surface antigen from e-antigen-positive sera on insolubilized cross-linked albumin

A. Neurath, N. Strick, 2005, Archives of Virology.

Enzyme-linked immunoassay of pre-S gene-coded sequences in hepatitis B vaccines.

S. Kent, J. Christman, W. Offensperger, 1985, Journal of virological methods.

Confirmatory evidence for the association of hepatitis B surface antigen with antigenic determinants reactive with antibodies present in some anti-HBe-positive sera.

C. Y. Huang, A. Neurath, N. Strick, 1980, The Journal of general virology.

Host specificity of a serum marker for hepatitis B: evidence that "e antigen" has the properties of an immunoglobulin.

A. Neurath, N. Strick, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Discovery of a Cytoplasmic‐Dominant Alloantigen Prevalent in Erythrocytes

A. Rowe, N. Strick, P. Rubinstein, 1981, Vox sanguinis.

Antigenic sites related to human serum proteins in HBsAg: Isolation from normal human serum of a high‐molecular‐weight glycoprotein reacting with antialbumin

C. Y. Huang, N. Strick, A. Prince, 1978, Journal of medical virology.

Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein.

S. Kent, W. Offensperger, A. Budkowska, 1986, Molecular immunology.

Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139-147).

A. Neurath, N. Strick, M. Pride, 1990, Peptide research.

Detection of receptors for hepatitis B virus on cells of extrahepatic origin.

A. Neurath, N. Strick, J. Valinsky, 1990, Virology.

Monoclonal antibodies to hepatitis B surface antigen (HBsAg) with anti-alpha specificity recognize a synthetic peptide analogue (S135-155) with unmodified lysine (141).

S. Kent, A. Neurath, N. Strick, 1984, Journal of virological methods.

Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus.

S. Kent, A. Neurath, N. Strick, 1984, Science.

Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders.

S. Karpatkin, N. Strick, M. Karpatkin, 1972, The American journal of medicine.

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.

A M Prince, S. Kent, A. Neurath, 1986, Vaccine.

The putative cell receptors for hepatitis B virus (HBV), annexin V, and apolipoprotein H, bind to lipid components of HBV.

A. Neurath, N. Strick, 1994, Virology.

Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein

A. Neurath, N. Strick, Y. Li, 1992, The Journal of experimental medicine.

Antigenic mimicry of an immunoglobulin A epitope by a hepatitis B virus cell attachment site.

A. Neurath, N. Strick, 1990, Virology.

Radioimmunoassay of human beta interferon.

A. Neurath, N. Strick, N. Raj, 1982, Journal of interferon research.

Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes.

S. Kent, A. Budkowska, A. Neurath, 1987, Molecular immunology.

B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.

A. Neurath, N. Strick, E. Lee, 1990, The Journal of general virology.

Delineation of contiguous determinants essential for biological functions of the pre-S sequence of the hepatitis B virus envelope protein: its antigenicity, immunogenicity and cell-receptor recognition.

S. Kent, A. Neurath, N. Strick, 1988, Annales de l'Institut Pasteur. Virology.

Detection of antiviral antibodies with predetermined specificity using synthetic peptide--beta-lactamase conjugates: application to antibodies specific for the preS region of the hepatitis B virus envelope proteins.

S. Kent, A. Neurath, N. Strick, 1986, The Journal of general virology.

Immunological cross-reactivity between preS2 sequences of the hepatitis B virus envelope proteins corresponding to serological subtypes adw2 and ayw.

S. Kent, P. Price, A. Budkowska, 1987, Molecular immunology.

Association of hepatitis B e-antigen (HBeAg) determinants with the core of Dane particles.

A. Neurath, N. Strick, 1979, The Journal of general virology.

Vaccination with Synthetic Hepatitis B Virus Peptides

S. Kent, A. Neurath, N. Strick, 1988 .

Localization of a hepatitis B surface antigen determinant deduced from results of chemical modifications.

A. Neurath, N. Strick, W. Oleszko, 1981, Journal of virological methods.

Properties of delipidated hepatitis B surface antigen (HBsAg) and preparation of its proteolytic cleavage fragments carrying HBsAg-specific antigenic determinants.

A. Neurath, N. Strick, C. Huang, 1978, Intervirology.

Radioimmunoassays of hidden viral antigens.

A. Neurath, N. Strick, S. Krugman, 1982, Developments in biological standardization.

Heterogeneity of human platelets. V. Differences in glycolytic and related enzymes with possible relation to platelet age.

S. Karpatkin, N. Strick, 1972, The Journal of clinical investigation.

Advances in understanding structure-function relationships in hepatitis B virus (HBV) envelope (ENV) proteins.

A. Neurath, N. Strick, 1989, Advances in experimental medicine and biology.

e/ANTI-e IN HEPATITIS B, AN ANTIBODY/ANTI-ANTIBODY SYSTEM

A. Neurath, N. Strick, 1977, The Lancet.

Punica granatum (Pomegranate) Juice Provides an HIV‐1 Entry Inhibitor and Candidate Topical Microbicide

A. Debnath, A. Neurath, N. Strick, 2005, Annals of the New York Academy of Sciences.

Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide

A. Debnath, A. Neurath, N. Strick, 2004, BMC infectious diseases.

Antibodies to hepatitis B surface antigen (HBsAg) elicited by immunization with a synthetic peptide covalently linked to liposomes.

S. Kent, A. Neurath, N. Strick, 1984, The Journal of general virology.

Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.

S. Jiang, A. Neurath, N. Strick, 1993, AIDS research and human retroviruses.

Detection of Splenic Anti‐Platelet Antibody Synthesis in Idiopathic Autoimmune Thrombocytopenic Purpura (ATP)

S. Karpatkin, N. Strick, G. Siskind, 1972, British journal of haematology.

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Asim Kumar Debnath, Shibo Jiang, Nouri Neamati, 2005, Virology.

Bovine β–lactoglobulin modified by 3–hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV

Shibo Jiang, A. Debnath, Shibo Jiang, 1996, Nature Medicine.

Evidence against the postulated identity of e-antigen with DNA polymerase associated with the hepatitis B candidate virus.

A. Neurath, N. Strick, 1976, Intervirology.

Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1).

A. Neurath, N. Strick, 1990, Molecular immunology.

Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).

R. Gallo, A. Neurath, N. Strick, 1985, Journal of virological methods.

3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses.

A. Neurath, N. Strick, Y. Li, 1998, Antiviral chemistry & chemotherapy.

Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.

S. Jiang, A. Neurath, N. Strick, 1993, Biochemical and biophysical research communications.

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

A. Debnath, S. Jiang, A. Neurath, 1994, Journal of medicinal chemistry.

Antibody response to two synthetic peptides corresponding to residues 45-68 and 69-79 of the major protein of hepatitis B surface antigen.

S. Kent, A. Neurath, N. Strick, 1984, Virus research.

Expression in Escherichia coli of a cloned DNA sequence encoding the pre-S2 region of hepatitis B virus.

S. Kent, J. Christman, P. Price, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Radioimmunoassay and some properties of human antibodies to hepatitis B core antigen.

A. Neurath, N. Strick, W. Szmuness, 1978, The Journal of general virology.

Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV‐1) by chemically modified bovine milk proteins: Potential for AIDS prophylaxis

A. Debnath, Shibo Jiang, A. Neurath, 1995, Journal of molecular recognition : JMR.

Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120

A. Debnath, N. Strick, Yun-yao Li, 2001, BMC infectious diseases.

Water dispersible microbicidal cellulose acetate phthalate film.

N. Strick, Yun-yao Li, A. Neurath, 2003 .

Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV‐1) envelope glycoprotein gp120

A. Debnath, A. Neurath, N. Strick, 1995, Journal of molecular recognition : JMR.

Automated enzyme-linked fluorescence immunoassays for antiviral antibodies: a test for anti-HBs.

A. Neurath, N. Strick, S. Goodman, 1982, Journal of virological methods.